Opendoor’s Q3 Revenue Miss Reinforces Wait as Turnaround Lacks Profit Confirmation

What happened

Opendoor reported third-quarter fiscal 2026 results after the close on November 5, missing analysts’ revenue expectations, per Benzinga. The miss follows a Q2 2026 that showed operational progress—revenue of $883 million, contribution margin of 5.8%, and aged inventory above 120 days at just 9%—but adjusted EBITDA remained negative $4 million and free cash flow was -$973 million, leaving little room for error. The revenue shortfall now raises concerns that acquisition growth may be cooling or that resale clearance is slowing in a still-constrained housing market with mortgage rates near 6.5%. Our prior wait thesis hinged on seeing sustained contribution margin above 5%, positive adjusted EBITDA, and controlled inventory aging; without those, the stock’s valuation at $3.50 already assumes a turnaround that has not been proven. The Q3 miss is an early negative signal, but we need full details on margins and inventory before adjusting our stance materially.

Implication

The Q3 revenue miss underscores that Opendoor’s operating improvements are not yet translating into reliable top-line growth, and with adjusted EBITDA barely breakeven in Q2, any slowdown in revenue puts the path to profitability at risk. Investors should watch three key items in the Q3 report: contribution margin relative to the 5–7% target, the share of inventory aged over 120 days (which was 9% in Q2 but could rise if sales slow), and whether adjusted EBITDA turned positive. If contribution margin holds but revenue misses because of lower home purchases, that suggests demand-side weakness rather than execution failure, which is still negative for near-term earnings. Our base-case valuation of $3.80 assumed gradual improvement, but the miss tilts risks toward the bear scenario of $2.25 if margins and inventory deteriorate from here. Until management demonstrates at least two consecutive quarters with margin above 5% and positive adjusted EBITDA, the stock is likely to remain range-bound with downside risk to our $2.75 attractive entry.

Thesis delta

The thesis remains a 'wait,' but the revenue miss increases the probability that the bear scenario unfolds. Previously we saw Q2 progress as evidence that acquisition growth could convert into profits; now we need to see whether Q3 miss was volume-driven or margin-driven. The core conditions for a buy—contribution margin above 5% and positive adjusted EBITDA—are unchanged, but our confidence in near-term achievement has declined modestly, so we maintain our wait rating and lower entry price as potential support.